DMAA today
$10.88+$0.00 (+0.00%)close Nov 6, 2026Trend
DailyUptrend (confirmed)
4 hourBullish
1 hourBullish
15 minBullish
5 minNo data
Daily trend turns down below $10.52
Key levels
Support$10.57
Support$10.55
Latest news & SEC filings
DealDrugs Made In America Acquisition Corp. revises merger valuation terms
SEC FilingDrugs Made In America Acquisition Corp. filed a report on a major company event (Form 8-K)
All DMAA news →About Drugs Made In America Acquisition
Drugs Made In America Acquisition is a blank check company formed to merge with or acquire one or more businesses. It has no operations of its own and holds proceeds in a trust account. The company targets businesses in artificial intelligence, pharmaceuticals, or other sectors requiring rapid innovation, primarily in the United States. It has signed a letter of intent with Power Analytics Global Corp. for a potential business combination.
Based on the company's 10-K filed Apr 15, 2026.
Nasdaq · Financial
Drugs Made In America Acquisition Corp. (DMAA)
What Is the Price Target for DMAA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is DMAA a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DMAA.
Start Free Trial →Is DMAA Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
0
Moat Score
NONE
1/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with DMAA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DMAA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for DMAA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DMAA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:01:48 | $10.88 | 5,000 | $$54K | SELL |
| 18:51:34 | $10.88 | 10,000 | $$109K | MIDPOINT |
| 18:51:01 | $10.88 | 4,500 | $$49K | MIDPOINT |
| 18:51:01 | $10.88 | 2,500 | $$27K | SELL |
| 18:50:48 | $10.88 | 3,700 | $$40K | SELL |
5 dark pool trades shown · $$279K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Drugs Made In America Acquisition Corp. (DMAA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DMAA — frequently asked questions
What is DMAA stock price today?
Drugs Made In America Acquisition Corp. (DMAA) is at $10.88, up 0.00% (+$0.00) at the Nov 6, 2026 close.
Why is DMAA stock moving today?
Latest DMAA news — Oct 22, 2026: Drugs Made In America Acquisition Corp. revises merger valuation terms · Oct 21, 2026: Drugs Made In America Acquisition Corp. filed a report on a major company event (Form 8-K)
What are DMAA support and resistance levels?
Support: $10.57, $10.55, $10.53.
What are insiders doing with DMAA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on DMAA?
Oct 22, 2026: Drugs Made In America Acquisition Corp. revises merger valuation terms · Oct 21, 2026: Drugs Made In America Acquisition Corp. filed a report on a major company event (Form 8-K)